Blocknomi
TLDR Zealand Pharma shares declined approximately 25% following Phase III survodutide data revealing significant patient dropout numbers Between 23% and 25% of trial participants discontinued survodutide treatment due to digestive…
Related articles
-
ETH/BTC Hits Historical Support Zone — Could An Ethereum Reversal Be Next?
Bitcoinist Published 07.06.2026 16:00
-
ETH vs SpaceX Hype: Can Ethereum Compete With the New AI-IPO Risk Trade?
Crypto Daily Published 15.06.2026 06:31
-
How Likely Was Zcash Exploited? Grayscale CLO Points To On-Chain Odds
Bitcoinist Published 08.06.2026 07:30
-
Curve changes DeFi lending model with Llamalend v2 upgrade
Crypto.News Published 10.06.2026 22:53
-
Mastercard Enables AI Agent Payments With Help From Crypto Giants Like Coinbase, Ripple
Decrypt Published 10.06.2026 16:50
-
Casper Network launches AI toolkit with autonomous payments and app-building tools
Crypto.News Published 04.06.2026 14:00
-
Cardano’s Charles Hoskinson Plots Exit From X to Discord Over ‘Endless Rage’
CryptoPotato Published 12.06.2026 18:33
-
Visa tests private stablecoin settlement with Brale, Canton
Cointelegraph Published 05.06.2026 14:45